Stoke Therapeutics, Inc.'s revenue has grown 146% a year over three years. Revenue growth, 3-year annual rate: +146% (Biotechnology median +21%). Years of annual history on file: 8, FY2018 to FY2025, as filed.

STOKStoke Therapeutics, Inc.

Healthcare

$25.01-27% 1Y

$25.01

$22.3752 weeks$38.35

Is it growing?

Watch

Growth is fading: revenue shrinking (−86% year on year) and operating margin narrowing (−1386.5 points).

2 to watch, 1 without data

Revenue trend−86% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−1386.5 points operating

Trailing-twelve-month operating margin, -1586.7% now against -200.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.